| Loci on 7p12. 2, 10q21. 2 and 14q11. 2 are associated with risk of childhood acute lymphoblastic leukemia E Papaemmanuil, FJ Hosking, J Vijayakrishnan, A Price, B Olver, ... Nature genetics 41 (9), 1006-1010, 2009 | 579 | 2009 |
| A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia MC Di Bernardo, D Crowther-Swanepoel, P Broderick, E Webb, G Sellick, ... Nature genetics 40 (10), 1204-1210, 2008 | 462 | 2008 |
| Cancer survivorship—genetic susceptibility and second primary cancers: research strategies and recommendations LB Travis, CS Rabkin, LM Brown, JM Allan, BP Alter, CB Ambrosone, ... Journal of the National Cancer Institute 98 (1), 15-25, 2006 | 399 | 2006 |
| Mechanisms of therapy-related carcinogenesis JM Allan, LB Travis Nature reviews cancer 5 (12), 943-955, 2005 | 358 | 2005 |
| Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia JM Allan, CP Wild, S Rollinson, EV Willett, AV Moorman, GJ Dovey, ... Proceedings of the National Academy of Sciences 98 (20), 11592-11597, 2001 | 347 | 2001 |
| Testicular cancer survivorship: research strategies and recommendations LB Travis, C Beard, JM Allan, AA Dahl, DR Feldman, J Oldenburg, ... Journal of the national cancer institute 102 (15), 1114-1130, 2010 | 326 | 2010 |
| Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk AL Sherborne, FJ Hosking, RB Prasad, R Kumar, R Koehler, ... Nature genetics 42 (6), 492-494, 2010 | 315 | 2010 |
| Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase BP Engelward, G Weeda, MD Wyatt, JLM Broekhof, J De Wit, I Donker, ... Proceedings of the National Academy of Sciences 94 (24), 13087-13092, 1997 | 296 | 1997 |
| Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors LB Travis, WD Wahnefried, JM Allan, ME Wood, AK Ng Nature reviews Clinical oncology 10 (5), 289-301, 2013 | 293 | 2013 |
| Common variants at 2q37. 3, 8q24. 21, 15q21. 3 and 16q24. 1 influence chronic lymphocytic leukemia risk D Crowther-Swanepoel, P Broderick, MC Di Bernardo, SE Dobbins, ... Nature genetics 42 (2), 132-136, 2010 | 284 | 2010 |
| Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition J Irving, E Matheson, L Minto, H Blair, M Case, C Halsey, I Swidenbank, ... Blood, The Journal of the American Society of Hematology 124 (23), 3420-3430, 2014 | 279 | 2014 |
| Second malignant neoplasms and cardiovascular disease following radiotherapy LB Travis, AK Ng, JM Allan, CH Pui, AR Kennedy, XG Xu, JA Purdy, ... Journal of the National Cancer Institute 104 (5), 357-370, 2012 | 260 | 2012 |
| 3‐methyladenine DNA glycosylases: structure, function, and biological importance MD Wyatt, JM Allan, AY Lau, TE Ellenberger, LD Samson Bioessays 21 (8), 668-676, 1999 | 254 | 1999 |
| Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia K Sibley, S Rollinson, JM Allan, AG Smith, GR Law, PL Roddam, ... Cancer research 63 (15), 4327-4330, 2003 | 248 | 2003 |
| A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia HE Speedy, MC Di Bernardo, GP Sava, MJS Dyer, A Holroyd, Y Wang, ... Nature genetics 46 (1), 56-60, 2014 | 233 | 2014 |
| Common variation at 3q26. 2, 6p21. 33, 17p11. 2 and 22q13. 1 influences multiple myeloma risk D Chubb, N Weinhold, P Broderick, B Chen, DC Johnson, A Försti, ... Nature genetics 45 (10), 1221-1225, 2013 | 190 | 2013 |
| A chemical and genetic approach together define the biological consequences of 3-methyladenine lesions in the mammalian genome BP Engelward, JM Allan, AJ Dreslin, JD Kelly, MM Wu, B Gold, ... Journal of Biological Chemistry 273 (9), 5412-5418, 1998 | 180 | 1998 |
| DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents BJ Glassner, G Weeda, JM Allan, JLM Broekhof, NHE Carls, I Donker, ... Mutagenesis 14 (3), 339-347, 1999 | 179 | 1999 |
| Variation at 10p12. 2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype G Migliorini, B Fiege, FJ Hosking, Y Ma, R Kumar, AL Sherborne, ... Blood, the Journal of the American Society of Hematology 122 (19), 3298-3307, 2013 | 168 | 2013 |
| Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial MS Braun, SD Richman, L Thompson, CL Daly, AM Meade, JW Adlard, ... Journal of clinical oncology 27 (33), 5519-5528, 2009 | 165 | 2009 |
Julie IrvingNewcastle University在 ncl.ac.uk 的电子邮件经过验证
